News from IVAC

April 2023

World Immunization Week 2023 (Webinar): Game Changers–Vaccine Innovations on the Horizon

When: April 26th, 2023 Recording: https://youtu.be/DFRzAPvfEO8 Slides: (download PDF) Description: As part of World Immunization Week (2023), IVAC is hosted a webinar to highlight exciting new vaccines and immunization technologies that are on the horizon. An international panel of distinguished experts presented on cutting-edge developments in vaccines. The experts covered new vaccines that have the […]

Read More >
March 2023

Breaking the Barriers: How Gender Equity Advances Immunization

Gender roles and norms can profoundly impact immunization uptake and health outcomes for women, children, families, and communities. In order to support immunization coverage and reach zero-dose children, it is essential to understand and address how gender can influence the access and delivery of vaccines. In recognition of International Women’s Day on March 8, IVAC […]

Read More >
March 2023

World Tuberculosis Day 2023: The Promise of TB Vaccines

World Tuberculosis Day is observed annually on March 24 to raise awareness about this devastating disease, which infects more than 10 million people and kills approximately 1.6 million each year—equal to one TB death every 20 seconds. TB is currently one of the world’s leading infectious killers, second only to COVID-19, though it has received […]

Read More >
March 2023

IVAC’s VIRA Chatbot Receives Silver Anthem Award for Innovative Approach to Vaccine Communication 

COVID-19 vaccine uptake has plateaued globally, largely in part due to rampant misinformation about the vaccine’s safety and effectiveness. To combat this phenomenon, IVAC launched VIRA, the COVID-19 vaccine chatbot, at the peak of the pandemic in July 2021. VIRA was developed in partnership with IBM Research with the goal of providing evidence-based, credible, and […]

Read More >
February 2023

IVAC Economics & Finance Team Highlights Immunization Financing Gap

IVAC health economists, led by Bryan Patenaude, ScD, have recently published several papers focusing on the cost of procuring and delivering life-saving vaccines to increase coverage and meet Immunization Agenda 2030 (IA 2030) targets. Despite the sizable global investment in immunization programs over the past few decades, a considerable gap remains between the funding available […]

Read More >
January 2023

IVAC engages with Jordan on introduction of the Pneumococcal Conjugate Vaccine (PCV) – a life-saving vaccine for children

Pneumonia continues to be the number one infectious killer of young children globally. In the World Health Organization (WHO)’s Eastern Mediterranean (EMRO) region, each year an estimated 923,000 children under 5 years of age (U5) die, with pneumonia accounting for over 20% of deaths among this age group (UNICEF, 2022). PCV protects against infections caused […]

Read More >